Pro-Gastrin-Releasing Peptide (eCLIA) is an immunoassay reagent for in vitro quantitative determination of pro-Gastrin Releasing Peptide in human serum and plasma by fully automated immunassay analyzer to aid clinical monitoring of small cell lung cancer (SCLC).
